Table 3. Base-case and univariate scenario analysis (2013 US$).

	ICER/Case	ICER/Death	ICER/DALY	Break-even price
Societal perspective
Base-case	6,252	26,476	1,231	0.69
Life expectancy of a sequelae case = 30 years	6,338	26,840	1,271	0.67
Discount rate=0% for cost and effectiveness	2,235	8,240	385	1.81
Discount rate=5% for cost	5,963	25,253	1,175	0.78
Meningitis incidence = 34/100,000 child-year	4,282	17,322	803	0.84
Clinical pneumonia incidence = 0.35/child-year	1,465	10,119	490	0.91
Productivity loss from death included	5,688	24,084	1,120	0.86
Governmental perspective
Base-case	6,954	29,449	1,370	0.48
Life expectancy of a sequelae case = 30 years	6,953	29,444	1,394	0.48
Discount rate=0% for cost and effectiveness	5,350	19,720	923	0.72
Discount rate=5% for cost	6,883	29,147	1,356	0.5
Meningitis incidence=34/100000 child-year	5,037	20,381	945	0.54
Clinical pneumonia incidence=0.35/child-year	1,720	11,883	576	0.61

Note: ICER, incremental cost-effectiveness ratio; DALY, disability-adjusted life year.